SGLT2 inhibitors and amputations in the US FDA Adverse Event Reporting System.

アブストラクト
ジャーナル名	The lancet. Diabetes & endocrinology
投稿日	2017/7/25
投稿者	Fadini, Gian Paolo; Avogaro, Angelo
組織名	Division of Metabolic Diseases, Department of Medicine, University of Padova,;35128 Padova, Italy. Electronic address: gianpaolo.fadini@unipd.it.;35128 Padova, Italy.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/28733172/